Beyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy.

Trends in Cancer
Katherine E Baillie, Peter C Stirling

Abstract

DNA replication stress describes a state of impaired replication fork progress that triggers a cellular stress response to maintain genome stability and complete DNA synthesis. Replication stress is a common state that must be tolerated in many cancers. One promising therapeutic approach is targeting replication stress response factors such as the ataxia telangiectasia and rad 3-related kinase (ATR) or checkpoint kinase 1 (CHK1) kinases that some cancers depend upon to survive endogenous replication stress. However, research revealing the complexity of the replication stress response suggests new genetic interactions and candidate therapeutic targets. Many of these candidates regulate DNA transactions around reversed replication forks, including helicases, nucleases and alternative polymerases that promote fork stability and restart. Here we review emerging strategies to exploit replication stress for cancer therapy.

References

Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paolo CeppiGiorgio Scagliotti
Feb 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kirk J McManusPhilip Hieter
Feb 1, 2011·Journal of Molecular Cell Biology·Li Zheng, Binghui Shen
Jan 27, 2012·Human Molecular Genetics·Andrew N BlackfordWojciech Niedzwiedz
Nov 19, 2013·Nature Structural & Molecular Biology·Silvana MourónJuan Méndez
May 13, 2014·Cell Reports·Alessandra Pepe, Stephen C West
Jan 15, 2015·DNA Repair·Chantal StoepkerJohan P de Winter
Feb 26, 2015·Nature Reviews. Molecular Cell Biology·Kai J Neelsen, Massimo Lopes
Mar 4, 2015·The Journal of Cell Biology·Saravanabhavan ThangavelAlessandro Vindigni
Jun 9, 2015·Molecular Cell·Andrew C KileKarlene A Cimprich
Jul 15, 2015·Nature Communications·Jinxue HeWen H Shen
Sep 26, 2015·Cell Research·Guangxi WangYuxin Yin
Jan 11, 2016·Molecular Cell·Jutta ZimmerMadalena Tarsounas
Feb 14, 2016·Nucleic Acids Research·Fei HuangAlexander V Mazin
Apr 8, 2016·Cell Reports·Constance Qiao Xin YeoChit Fang Cheok
Jun 4, 2016·Biochemical and Biophysical Research Communications·Suhong XieRenquan Lu
Jul 23, 2016·Nature·Arnab Ray ChaudhuriAndré Nussenzweig
Jul 28, 2016·Bioorganic & Medicinal Chemistry·Marcelo L ActisNaoaki Fujii
Aug 16, 2016·Nature Chemical Biology·Jack C ExellJane A Grasby
Sep 17, 2016·Genome Biology·Nnennaya KanuCharles Swanton
Oct 12, 2016·Nature Communications·Panagiotis KotsantisEva Petermann
Oct 22, 2016·Molecular Cell·Advaitha MadireddyCarl L Schildkraut

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Molecular Sciences·Jessica J R Hudson, Ulrich Rass
Jun 17, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Khanh T DoGeoffrey I Shapiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.